This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (99)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Choroidal Neovascularization  • Retinal/ Chorioretinal Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Thomas A. Ciulla, MD; Mark H. Criswell, PhD; Ronald P. Danis, MD; Tiffany E. Hill, BS

Arch Ophthalmol. 2001;119:399-404.

Objective  To determine if intravitreal triamcinolone acetonide (TAAC) inhibits experimental choroidal neovascular membranes induced by laser trauma in a rat model.

Methods  Nineteen anesthetized male Brown Norway rats received a series of 8 krypton red laser lesions per eye (647 nm, 0.05 seconds, 50 µm, and 150 mW in 17 rats, and 200 mW in 2 rats). One eye received an intravitreal injection of triamcinolone acetonide (20 µL, 0.8 mg) and the other eye received an injection of isotonic sodium chloride solution. Fundus and fluorescein angiography examinations occurred just before euthanasia and tissue processing for histopathology on day(s) 0, 1, 3, 7, 14, 21, 28, and 35.

Results  From the control eyes that underwent photocoagulation at 150 mW, 57 discrete lesions with definitive fibrovascular proliferations were observed at 21, 28, and 35 days, arising from a total of 72 spots placed (79% yield). From the control eyes that underwent photocoagulation at 200 mW, 11 discrete lesions with definitive fibrovascular proliferations were observed at 28 days, arising from a total of 16 spots placed (69% yield). In the TAAC-treated group, no fibrovascular proliferations were observed in the 72 lesions and in the 16 lesions created with 150 mW and 200 mW, respectively.

Conclusion  Intravitreal TAAC is a potent inhibitor of fibrovascular proliferations in a rat model of choroidal neovascular membranes induced by laser trauma.

Clinical Relevance  This study corroborates previous investigations that propose TAAC as a potential treatment for choroidal neovascular membranes in humans.

From the Retina Service, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis. The authors have no financial or proprietary interest in the information presented.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early Effects of Intravitreal Triamcinolone Acetonide on Inflammation and Proliferation in Human Choroidal Neovascularization
Tatar et al.
Arch Ophthalmol 2009;127:275-281.
ABSTRACT | FULL TEXT  

Photoreceptor Protection after Photodynamic Therapy Using Dexamethasone in a Rat Model of Choroidal Neovascularization
She et al.
IOVS 2008;49:5008-5014.
ABSTRACT | FULL TEXT  

Combination of Photodynamic Therapy and Intraocular Triamcinolone for Exudative Age-Related Macular Degeneration and Long-Term Chorioretinal Macular Atrophy
Piermarocchi et al.
Arch Ophthalmol 2008;126:1367-1374.
ABSTRACT | FULL TEXT  

Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone
Iwama et al.
Br J Ophthalmol 2008;92:1352-1356.
ABSTRACT | FULL TEXT  

Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization
Tatar et al.
Arch Ophthalmol 2008;126:193-199.
ABSTRACT | FULL TEXT  

Angiogenesis Inhibition and Choroidal Neovascularization Suppression by Sustained Delivery of an Integrin Antagonist, EMD478761
Fu et al.
IOVS 2007;48:5184-5190.
ABSTRACT | FULL TEXT  

Positive Feedback Regulation between MMP-9 and VEGF in Human RPE Cells
Hollborn et al.
IOVS 2007;48:4360-4367.
ABSTRACT | FULL TEXT  

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study
Chan et al.
Br J Ophthalmol 2007;91:174-179.
ABSTRACT | FULL TEXT  

Perspectives on verteporfin therapy combined with intravitreal corticosteroids.
Schmidt-Erfurth et al.
Arch Ophthalmol 2006;124:561-563.
FULL TEXT  

Should corticosteroids be considered as part of the standard care with photodynamic therapy?
Zarbin
Arch Ophthalmol 2006;124:563-571.
FULL TEXT  

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan et al.
Br J Ophthalmol 2006;90:337-341.
ABSTRACT | FULL TEXT  

Toxicity of Triamcinolone Acetonide on Retinal Neurosensory and Pigment Epithelial Cells
Narayanan et al.
IOVS 2006;47:722-728.
ABSTRACT | FULL TEXT  

Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo
Spandau et al.
Br J Ophthalmol 2005;89:745-747.
ABSTRACT | FULL TEXT  

Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration
Jonas et al.
Br J Ophthalmol 2004;88:1557-1562.
ABSTRACT | FULL TEXT  

Trans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularisation
Okada et al.
Br J Ophthalmol 2004;88:1097-1098.
FULL TEXT  

Safety of an Intravitreal Injection of Triamcinolone: Results From a Randomized Clinical Trial
Gillies et al.
Arch Ophthalmol 2004;122:336-340.
ABSTRACT | FULL TEXT  

The Squirrel Monkey: Characterization of a New-World Primate Model of Experimental Choroidal Neovascularization and Comparison with the Macaque
Criswell et al.
IOVS 2004;45:625-634.
ABSTRACT | FULL TEXT  

Noninfectious Endophthalmitis Associated With Intravitreal Triamcinolone Injection
Roth et al.
Arch Ophthalmol 2003;121:1279-1282.
ABSTRACT | FULL TEXT  

Macrophage Depletion Diminishes Lesion Size and Severity in Experimental Choroidal Neovascularization
Espinosa-Heidmann et al.
IOVS 2003;44:3586-3592.
ABSTRACT | FULL TEXT  

Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants
Ciulla et al.
Br J Ophthalmol 2003;87:1032-1037.
ABSTRACT | FULL TEXT  

A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration: One-Year Results
Gillies et al.
Arch Ophthalmol 2003;121:667-673.
ABSTRACT | FULL TEXT  

Intravitreal triamcinolone acetonide for exudative age related macular degeneration
Jonas et al.
Br J Ophthalmol 2003;87:462-468.
ABSTRACT | FULL TEXT  

Intraocular pressure after intravitreal injection of triamcinolone acetonide
Jonas et al.
Br J Ophthalmol 2003;87:24-27.
ABSTRACT | FULL TEXT  

Modulation of Permeability and Adhesion Molecule Expression by Human Choroidal Endothelial Cells
Penfold et al.
IOVS 2002;43:3125-3130.
ABSTRACT | FULL TEXT  

Intravitreal triamcinolone in recurrence of choroidal neovascularisation
Penfold
Br J Ophthalmol 2002;86:600-601.
FULL TEXT